40,458 results on '"hepatitis A"'
Search Results
2. Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
3. Early Detection of HCV in Injection Drug Users (EDVIP)
4. A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
5. Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B (i-LIVER)
6. Nutritional Interventions in Patients With Alcohol-associated Hepatitis
7. HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
8. HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection
9. Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
10. The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. (Promote)
11. Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
12. An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants (OCTOPUS-1)
13. A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection (OSPREY)
14. A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (REEF-D)
15. Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
16. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
17. Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
18. Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)
19. Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
20. Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.
21. Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
22. Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
23. Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
24. Evaluation of Patients With Liver Disease
25. Exposure to Hepatitis E Virus in Occitania, France (EVE)
26. A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
27. DBS TaT in Peer-assisted Telemedicine for Hepatitis C
28. A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
29. DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B) (DETECT-B)
30. Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD) (D-SHIELD)
31. Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
32. Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) (REHEB)
33. A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites
34. Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
35. Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
36. Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
37. Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection
38. Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) (B-Together)
39. Maraviroc Efficacy for Hepatitis C (MAVERIC)
40. A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
41. Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM
42. Belimumab in Autoimmune Hepatitis (BELief)
43. Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
44. SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
45. Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection (MARCH)
46. Hepatitis C Lab Testing Comparison Study
47. Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
48. Digoxin In Treatment of Alcohol Associated Hepatitis (DIGIT-AlcHep)
49. Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
50. A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.